Faculty Research

Gerald L. Andriole, Jr., M.D. – Studies include:

• Prostate, Lung, Colon and Ovarian (PLCO) Cancer Screening Trial, funded by the National Institutes of Health (NIH)/National Cancer Institute (NCI)

• Complementary and Alternative Medicine for Urinary Symptoms (CAMUS) study (NIH/NIDDK)
• REDUCE (REduction by DUtasteride of prostate Cancer Events) study

Paul F. Austin, M.D. – The physiological effects of bladder outlet obstruction, which can lead to negative health consequences including, ultimately, renal failure.

Jeffrey M. Arbeit, M.D. – Research determining the molecular control of epithelial and prostate carcinogenesis.

Sam Bhayani, M.D. - Studying the prevention of prostate cancer in men who are at high risk. Dr. Bhayani also is involved in a trial studying the effects of a drug on hot flashes in men on hormonal therapy.

Arnold D. Bullock, M.D. – Conducting trials in men’s health with relation to the prostate. Dr. Bullock has a large trial targeting the prevention of prostate cancer. Other trials include urgency and frequency symptoms in men and prevention of bone fractures in men on hormonal therapy.

Adam S. Kibel, M.D. (Genitourinary Oncology Laboratory) – The genetics of urologic malignancies, specifically prostate cancer.

Carl G. Klutke, M.D. – Treating and studying varied aspects of urinary incontinence with surgery, medication and behavioral intervention. Presently conducting eight trials in these different treatments.

Steven J. Weintraub, M.D. – Basic aspects of apoptosis and cell cycle control in the context of complex biological phenomena, including mechanistic studies of (1) the response of urologic and other malignancies to antineoplastic agents and (2) the bladder smooth muscle hyperplastic response that occurs when there is a bladder outlet obstruction.

Ramakrishna Venkatesh, M.D. – Ureteral physiology studies using minimally invasive technology; stone, endourologic and laparoscopic research studies.